Association between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis

被引:7
作者
Chen, Xi [1 ]
Ou, Yili [1 ]
Wang, Zhicong [1 ,2 ]
Liu, Hailong [1 ]
Liu, Yuehong [1 ]
Liu, Mozhen [2 ]
机构
[1] Peoples Hosp Deyang City, Dept Orthoped, Deyang, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Dept Orthoped, Dalian, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 10卷
关键词
systemic immune-inflammation index; lower extremity deep venous thrombosis; inflammation; risk factor; biomarker; VEIN THROMBOSIS;
D O I
10.3389/fcvm.2023.1211294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe systemic immune-inflammation index (SII), as a novel inflammatory biomarker, has recently attracted attention in cardiovascular disease research. However, the relationship between SII and risk of lower extremity deep venous thrombosis (LEDVT) remains unclear to date. Thus, this study aimed to explore the association in a large sample over a 10-year period (2012-2022). MethodsAll hospitalized patients undergoing lower extremity compression ultrasonography (CUS) examination were consecutively screened by searching our hospital information system database. The receiver operating characteristic (ROC) curve analysis was used to identify the optimal cut-off value for high and low SII group. Multivariate logistic regression analyses were performed to investigate the relationship between SII and LEDVT risk. Propensity score matching (PSM), subgroup and sensitivity analyses were also conducted. Moreover, restricted cubic spline (RCS) regression and two-piecewise linear regression models were used to assess the dose-response relationship between natural log transformed SII [ln(SII)] and risk of LEDVT. ResultsA total of 16,725 consecutive hospitalized patients were included, and 1,962 LEDVT events occurred. After adjusting for confounding factors, patients in the high SII group (& GE; 574.2 x 10(9)/L) showed a 1.740-fold risk of LEDVT (95% CI: 1.546-1.959, P < 0.001), and elevated ln(SII) was associated with a 36.1% increased risk of LEDVT (95% CI: 1.278-1.449, P < 0.001). PSM, subgroup and sensitivity analyses confirmed the robustness of the association. A non-linear relationship was observed (P (non-linear )< 0.001), with a threshold value of 5.6 x 10(9)/L for all LEDVT events. Above the threshold, each unit increase in ln(SII) had a 1.369-fold higher risk of LEDVT (95% CI: 1.271-1.475, P < 0.001). The association also existed in both distal and proximal LEDVT. ConclusionElevated SII is significantly associated with an increased risk of LEDVT in hospitalized patients. Additionally, the association is non-linear and exhibit a threshold effect.
引用
收藏
页数:12
相关论文
共 40 条
[1]  
[Anonymous], 2002, ZHONGHUA LIU XING BI, V23, P5, DOI DOI 10.3760/J.ISSN:0254-6450.2002.01.003
[2]   Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy [J].
Bhatt, Meha ;
Braun, Cody ;
Patel, Payal ;
Patel, Parth ;
Begum, Housne ;
Wiercioch, Wojtek ;
Varghese, Jamie ;
Wooldridge, David ;
Alturkmani, Hani J. ;
Thomas, Merrill ;
Baig, Mariam ;
Bahaj, Waled ;
Khatib, Rasha ;
Kehar, Rohan ;
Ponnapureddy, Rakesh ;
Sethi, Anchal ;
Mustafa, Ahmad ;
Nieuwlaat, Robby ;
Lim, Wendy ;
Bates, Shannon M. ;
Lang, Eddy ;
Le Gal, Gregoire ;
Righini, Marc ;
Husainat, Nedaa M. ;
Kalot, Mohamad A. ;
Al Jabiri, Yazan Nayif ;
Schunemann, Holger J. ;
Mustafa, Reem A. .
BLOOD ADVANCES, 2020, 4 (07) :1250-1264
[3]   Immune Factors in Deep Vein Thrombosis Initiation [J].
Budnik, Ivan ;
Brill, Alexander .
TRENDS IN IMMUNOLOGY, 2018, 39 (08) :610-623
[4]   Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: Results from NHANES [J].
Cao, Yang ;
Li, Pengxiao ;
Zhang, Yan ;
Qiu, Miaohan ;
Li, Jing ;
Ma, Sicong ;
Yan, Yudong ;
Li, Yi ;
Han, Yaling .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[5]   A comparison of different methods to handle missing data in the context of propensity score analysis [J].
Choi, Jungyeon ;
Dekkers, Olaf M. ;
le Cessie, Saskia .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2019, 34 (01) :23-36
[6]   Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review [J].
Chopard, Romain ;
Albertsen, Ida Ehlers ;
Piazza, Gregory .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17) :1765-1776
[7]   The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper [J].
Cosmi, Benilde ;
Stanek, Agata ;
Kozak, Matja ;
Wennberg, Paul W. ;
Kolluri, Raghu ;
Righini, Marc ;
Poredos, Pavel ;
Lichtenberg, Michael ;
Catalano, Mariella ;
De Marchi, Sergio ;
Farkas, Katalin ;
Gresele, Paolo ;
Klein-Wegel, Peter ;
Lessiani, Gianfranco ;
Marschang, Peter ;
Pecsvarady, Zsolt ;
Prior, Manlio ;
Puskas, Attila ;
Szuba, Andrzej .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[8]   Inflammation in Cerebral Venous Thrombosis [J].
Ding, Jiayue ;
Song, Baoying ;
Xie, Xiran ;
Li, Xaingyu ;
Chen, Zhiying ;
Wang, Zhongao ;
Pan, Liqun ;
Lan, Duo ;
Meng, Ran .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[9]   Deep vein thrombosis symptoms and 30-day mortality in acute pulmonary embolism [J].
Dubois-Silva, Alvaro ;
Barbagelata-Lopez, Cristina ;
Pineiro-Parga, Patricia ;
Lopez-Jimenez, Luciano ;
Riera-Mestre, Antoni ;
Schellong, Sebastian ;
Catella, Judith ;
Bosevski, Marijan ;
Toledo, Mireia Roca ;
Monreal, Manuel .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 108 :43-51
[10]   Pulmonary embolism and deep vein thrombosis-comorbidities and temporary provoking factors in a register-based study of 1.48 million people [J].
Glise Sandblad, Katarina ;
Rosengren, Annika ;
Sorbo, Jan ;
Jern, Sverker ;
Hansson, Per-Olof .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (04)